Featured Content
The Center for Life Science Ventures was founded in 2008 as a startup incubator to help develop young Cornell life science companies. The Center is funded through the Office of the Vice President for Research and Innovation, the Institute of Biotechnology and NYSTAR.
The Center’s program focuses on accelerating research and development of its client’s companies’ technology and products, validating its client companies’ business plans, and strengthening their management teams. The Center’s goal is to facilitate the forward progress of client companies to the point where each will merit significant outside investment, and achieve self-sufficiency. In doing so, the Center for Life Science Ventures contributes to the University’s mission as New York State’s Morrill Land Grant institution to support local, regional, and state-wide Life Sciences jobs/economic development.
News
TETmedical Receives FDA Breakthrough Device Designation for NSE-FAST®, the First Rapid Test Designed to Aid in the Diagnosis of Acute Ischemic Stroke
1782086400
June 22, 2026 07:30 ET | Source: TETmedical, Inc. FAIR HAVEN, N.J. and ITHACA, N.Y., June 22, 2026 (GLOBE NEWSWIRE) — TETmedical, Inc., a clinical stage medical diagnostics company developing rapid tools for diagnosing acute neurological injury …
Kanvas Biosciences raises $48 million to advance microbiome cancer therapies
1781568000
By Reese Abrahamson June 8, 2026 LinkedInFacebookTwitterEmailShare Kanvas Biosciences is taking a major step forward in microbiome therapeutics with the announcement of $48 million in Series A funding, which will support a clinical trial later this year for the …
REEgen and RETRN Bio to establish local manufacturing space
1773705600
Two members of Cornell’s on-campus business incubators will soon expand their businesses in Ithaca, creating local jobs and building capacity for future startups to grow in the region. REEgen, a Cornell spinout that engineers bacteria …
Inso Biosciences Developing Rapid Microfluidic Sample-to-Library Workflow for Nanopore Sequencing
1771200000
Researchers from Center for Life Science Ventures client Inso Biosciences and the University of Washington have developed a technology for isolating high-molecular-weight DNA and preparing libraries for nanopore sequencing directly from samples in a single …
